The role of aldosterone in the metabolic syndrome

Curr Hypertens Rep. 2011 Apr;13(2):163-72. doi: 10.1007/s11906-011-0182-2.


The metabolic syndrome associates metabolic abnormalities such as insulin resistance and dyslipidemia with increased waist circumference and hypertension. It is a major public health concern, as its prevalence could soon reach 30% to 50% in developed countries. Aldosterone, a mineralocorticoid hormone classically involved in sodium balance regulation, is increased in patients with metabolic syndrome. Besides its classic actions, aldosterone and mineralocorticoid receptor (MR) activation affect glucose metabolism, inducing insulin resistance through various mechanisms that involve oxidative stress, inflammation, and downregulation of proteins involved in insulin signaling pathways. Aldosterone and MR signaling exert deleterious effects on the cardiovascular system and the kidney that influence the cardiovascular risk associated with metabolic syndrome. Salt load plays a major role in cardiovascular injury induced by aldosterone and MR signaling. Large multicenter, randomized clinical trials testing the beneficial effects of MR antagonists on cardiovascular events and mortality in patients with metabolic syndrome are needed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aldosterone / blood
  • Aldosterone / physiology*
  • Cardiovascular System
  • Humans
  • Inflammation
  • Insulin Resistance
  • Lipids
  • Metabolic Syndrome / metabolism*
  • Obesity / blood
  • Receptors, Mineralocorticoid / metabolism


  • Lipids
  • Receptors, Mineralocorticoid
  • Aldosterone